Skip to main content

Tian Zhang

Adjunct Associate Professor in the Department of Medicine
Medicine, Medical Oncology
DUMC 103861, Durham, NC 27710
Dept of Medicine, Box 103861, Durham, NC 27710

Current Appointments & Affiliations


Adjunct Associate Professor in the Department of Medicine · 2021 - Present Medicine, Medical Oncology, Medicine

Recent Publications


Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis

Journal Article Clinical Genitourinary Cancer · April 1, 2025 Introduction: The impact of neoadjuvant immune checkpoint inhibitors (ICIs) on perioperative outcomes of radical nephrectomy (RN) with inferior vena cava (IVC) thrombectomy for renal cell carcinoma (RCC) remains unclear. This study aimed to assess the safe ... Full text Cite

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting.

Journal Article Urol Oncol · March 2025 Modern advances in systemic and localized therapies for patients with renal cell carcinoma (RCC) have significantly improved patients' outcomes. If disease progression occurs after initial treatment, clinicians often have multiple options for a first salva ... Full text Link to item Cite

First and Second-line Treatments in Metastatic Renal Cell Carcinoma.

Journal Article Eur Urol · February 2025 BACKGROUND AND OBJECTIVE: The treatment landscape for metastatic renal cell carcinoma (mRCC) has evolved significantly in recent years, leading to improved outcomes. The aim of this review is to provide clinicians with a practical guide for selecting first ... Full text Link to item Cite
View All Publications

Recent Grants


Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer

Clinical TrialSignificant Contributor · Awarded by National Institutes of Health · 2014 - 2023

Predicting patient-specific responses to personalize androgen deprivation therapy for prostate cancer

ResearchPrincipal Investigator · Awarded by H. Lee Moffitt Cancer Center & Research Institute · 2019 - 2022

Conditional lethality of copper and disulfiram as a therapeutic modality for prostate cancer

ResearchPrincipal Investigator · Awarded by V Foundation for Cancer Research · 2016 - 2022

View All Grants

Education, Training & Certifications


Duke University, School of Medicine · 2019 M.H.S.
Harvard Medical School · 2009 M.D.